Precigen (PGEN) FCF Margin (2012 - 2026)
Precigen (PGEN) posted quarterly FCF Margin of 189.34% for Q1 2026, up 107442.0% year-over-year from N/an in Q1 2025, and up 36.56% quarter-over-quarter from 298.47% in Q4 2025.
Precigen (PGEN) FCF Margin (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported FCF Margin for 15 consecutive years, with 189.34% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin rose 107442.0% year-over-year to 189.34%; the TTM figure through Mar 2026 stood at 355.97% (up 80980.0% YoY), while the FY2025 annual figure was 927.57%, up 81801.0% from the prior year.
- FCF Margin grew to 189.34% in Q1 2026 per PGEN's latest filing, from 298.47% in the prior quarter.
- Across five years, FCF Margin topped out at 106.22% in Q4 2022 and bottomed at 2361500.0% in Q3 2024.
- Historically, FCF Margin has averaged 256342.49% across 5 years, with a median of 1084.6% in 2023.
- Annual changes were most pronounced in 2023 — FCF Margin tumbled 172420546 bps — and 2025, when it soared 235823121 bps.
- Precigen's FCF Margin stood at 106.22% in 2022, then tumbled by 1315 bps to 1289.98% in 2023, then surged by 98 bps to 27.86% in 2024, then plunged by 971 bps to 298.47% in 2025, then soared by 37 bps to 189.34% in 2026.
- Business Quant data shows PGEN's FCF Margin at 189.34% in Q1 2026, 298.47% in Q4 2025, and 3268.79% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Precigen | 2.18 Bn | 2.18 Bn | 52.17 Mn | -33.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -33.11% |
| Mar 31, 2026 | -189.34% |
| Dec 31, 2025 | -298.47% |
| Sep 30, 2025 | -3,268.79% |
| Jun 30, 2025 | -2,382.71% |
| Mar 31, 2025 | -1,263.76% |
| Dec 31, 2024 | -27.86% |
| Sep 30, 2024 | -2,361,500.00% |
| Jun 30, 2024 | -3,546.72% |
| Mar 31, 2024 | -1,731.55% |
| Dec 31, 2023 | -1,289.98% |
| Sep 30, 2023 | -1,724,400.00% |
| Jun 30, 2023 | -905.43% |
| Dec 31, 2022 | 106.22% |
| Sep 30, 2022 | -194.54% |
| Jun 30, 2022 | -241.70% |
| Mar 31, 2022 | -345.26% |
| Dec 31, 2021 | 108.51% |
| Sep 30, 2021 | -578.70% |
| Jun 30, 2021 | -235.12% |